Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Update on SCH-503034 in the treatment of hepatitis C

Nov. 17, 2005

Recent patents describe novel anti-hepatitis agents

Nov. 17, 2005

Novel FXR activator shows promise in the treatment of hepatic fibrosis

Nov. 17, 2005

Novel therapeutics for gastrointestinal disorders claimed in recent Altana patent

Nov. 16, 2005

Telbivudine superior to lamivudine in phase III hepatitis B trial

Nov. 16, 2005

Interferon omega effective in phase II chronic hepatitis C study

Nov. 16, 2005

Polyenylphosphatidylcholine improves peginterferon-ribavirin HCV treatment

Nov. 16, 2005

HepeX-B shows promise in the prevention of immune escape in HBV-infected patients

Nov. 16, 2005

New data on the antiviral effects of Albuferon plus ribavirin in chronic hepatitis C

Nov. 16, 2005

First data on the E1E2/MF59C.1 hepatitis C vaccine in humans

Nov. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...